Dr Dale Taylor
Dale is a cell biologist by trade, with a background in biochemistry and microbial genetics.
He has more than 20 years' experience in the field of in vitro and in vivo malaria research, with interests in antimalarial drug resistance, pharmacokinetics (PK) and new drug discovery. Dale has been involved with H3D since 2012, when he was seconded to the team at UCT Pharmacology as a post-doctoral research fellow assisting H3D with their in vivo PK studies which had just begun at UCT. He joined H3D full time in 2015, and lead the in vivo PK team and the parasitology team from mid-2016 until the end of 2019.
Currently Dale oversees the daily running of the malaria biology platform, and co-leads the Malaria Core Team at H3D. He is responsible for managing all facets of the routine screening and the in vivo efficacy teams, and representing malaria biology as a whole at Operations level.